GI side effects are most frequent and include nausea (2544 %), diarrhea (1930 %), vomiting (824 %), constipation (1724 %), and abdominal pain (920 %) [[39], [40], [41], [42], [43], [44]]
Ben highlights the potential consequences: If weight loss and diabetes control are showing themselves to be so profitable at the moment, were going to be in this period of pharma fashion where these areas will dominate for the next 5-15 years
Funding Support for this work was provided by US National Institutes of Health grants R56DK123738 and R01DK123738 to E.E.S
Hepatology 41 : 668670 Le Witt P and Pfeiffe R (2002) Neurologic aspects of Wilson's disease: clinical manifestations and treatment considerations
The launch builds on the prescription and telehealth infrastructure (see news release dated June 9, 2026) and the Company's 503A sterile compounding agreement (see news release dated June 2, 2026), under which all of the Company's peptides including BPC-157 will be 100% compounded in the United States
doi:10.1007/s12011-019-01954-6
